ARCHER

SOAKMONT GROUP, INC. announces it has reached an agreement (Letter of Intent LOI) with a Canadian Regulated Financial Institution for a partnership and the creation of a regulated entity focused on cryptocurrency.

Retrieved on: 
Thursday, June 16, 2022
Crypto, ARCHER, Blockchain, Environment, Government, Insurance, Efficiency, Science and technology in Asia, Parliament, USD, CAD, ATC, News, Partnership, Trustee, Platform, Multimedia, Organization, Financial institution, Cryptocurrency, Security (finance), QC

QUEBEC CITY, QC, June 16, 2022 /PRNewswire/ -- SOAKMONT GROUP, INC. is delighted to announce its imminent partnership with ATLANTIC TRUST CORPORATION (ATC) a Canadian regulated Financial Institution.

Key Points: 
  • QUEBEC CITY, QC, June 16, 2022 /PRNewswire/ -- SOAKMONT GROUP, INC.is delighted to announce its imminent partnership with ATLANTIC TRUST CORPORATION (ATC) a Canadian regulated Financial Institution.
  • This new entity will also offer the Crypto market fully fiat-backed CAD and USD stablecoins.
  • Being supported by a regulated Canadian Financial Institution allows SOAKMONT to focus on all forms of private equity and real estate investment.
  • Once the agreement is finalized in Q3 2022 the subsidiary financial institution will launch with the multi-chain stablecoins.

BAE Systems’ ARCHER 155mm Mobile Howitzer Shortlisted by Swiss Armed Forces

Retrieved on: 
Friday, June 10, 2022
Defense, Technology, Aerospace, Other Technology, Manufacturing, Contracts, BAE Systems, Excalibur, Marketing, Swiss Armed Forces, BAE Systems AB, Armasuisse, Defense, Multimedia, BAE, ARCHER, Swedish Army, Credit, Swiss Federal Laboratories for Materials Science and Technology, Safety, Weapon

The Swiss government has shortlisted BAE Systems ARCHER 155mm mobile howitzer as one of the systems going into the final round of competition for its future artillery system.

Key Points: 
  • The Swiss government has shortlisted BAE Systems ARCHER 155mm mobile howitzer as one of the systems going into the final round of competition for its future artillery system.
  • View the full release here: https://www.businesswire.com/news/home/20220609006034/en/
    ARCHER is the ultimate shoot-and-scoot howitzer and is capable operating in challenging terrains.
  • (Credit: BAE Systems)
    ARCHER is a fully automated system purpose-built to keep pace with fast-moving land forces.
  • ARCHER is the most advanced wheeled 155mm howitzer in operation today and meets the requirements of the Swiss Armed Forces, said Stefan Lfstrm, director of marketing and sales at BAE Systems Bofors in Karlskoga, Sweden.

BAE Systems to showcase combat vehicles and advanced defense technologies during Eurosatory

Retrieved on: 
Tuesday, June 7, 2022
Defense, Technology, Aerospace, Manufacturing, Other Technology, Other Defense, Contracts, BAE Systems, Time, Foreign, Bronco All Terrain Tracked Carrier, Infantry fighting vehicle, IFV, CATV, Beowulf, NATO, Ground Forces of the Slovak Republic, Defense, Solution, Multimedia, Active protection system, Foreign Military Sales, BAE, United States Department of Defense, Swedish Army, BvS 10, Puma (IFV), APKWS, ARCHER, Acquisition, Credit, MVP, CV90, Infantry, Cold Weather, FMS, Satellite navigation device, Road, Telescopic sight, Eurosatory

BAE Systems will display a broad range of capabilities during the Eurosatory defense and security tradeshow in Paris June 13-17; including combat vehicles, artillery systems, and technologies for precision strike and situational awareness.

Key Points: 
  • BAE Systems will display a broad range of capabilities during the Eurosatory defense and security tradeshow in Paris June 13-17; including combat vehicles, artillery systems, and technologies for precision strike and situational awareness.
  • CV90: The CV90 is combat proven and trusted and exists in more than a dozen variants for different mission sets.
  • Check6: The Check-6 rear-vision system is a camera system for ground vehicles that provides high-quality situational awareness to ground forces.
  • In combat, the APKWS system has achieved over a 93 percent success rate when fired from rotary- and fixed-wing platforms.

Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results

Retrieved on: 
Monday, May 9, 2022
COVID-19, Amyotrophic lateral sclerosis, Forward-looking statement, Investment, Nerve Damage, HD, Private Securities Litigation Reform Act, Immune system, Brain, Nasdaq, GLOBE, ARCHER, Autoimmunity, GBS, Securities Exchange Act of 1934, Nephritis, Securities Act of 1933, Biomarker, Research, Eye, Geographic atrophy, CTA, Patient, Autoimmune disease, Complement component 1q, Program, Neurodegeneration, Severe cognitive impairment, Inflammation, Lupus nephritis, Drug Quality and Security Act, Degenerative disease, R, Waiha, Disease, Humour, IV, SEC, Terminology, G&A, Guillain, Autoimmune hemolytic anemia, ALS, Central nervous system, GA, Pharmaceutical industry, Vaccine, Risk management

BRISBANE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced progress across its broad pipeline of product candidates and reported first quarter 2022 financial results.

Key Points: 
  • I am very proud of the strong execution by the Annexon team in advancing our classical complement platform across multiple indications driven by aberrant complement activity.
  • Research and development (R&D) expenses: R&D expenses were $27.0 million for the quarter ended March 31, 2022, compared to $20.7 million for the quarter ended March 31, 2021.
  • General and administrative (G&A) expenses: G&A expenses were $8.4 million for the quarter ended March 31, 2022, compared to $5.5 million for the quarter ended March 31, 2021.
  • Annexon is rigorously developing a pipeline of diversified product candidates across multiple mid- to late- stage clinical trials, with clinical data anticipated throughout 2022 and 2023.

Annexon Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor, ANX007, in Patients with Geographic Atrophy

Retrieved on: 
Thursday, April 7, 2022
Risk, Geographic atrophy, AMD, Neurodegeneration, FAF, Patient, Probability, Retina, Intravitreal administration, Cleveland Clinic, Quality of life, ARCHER, Complement component 1q, Safety, Severe cognitive impairment, Nasdaq, Brain, Physician, B cell, GLOBE, Eye, Nerve Damage, Pharmaceutical industry, Vaccine, Ophthalmology

In a Phase 1b trial, ANX007 was well-tolerated and demonstrated full target engagement and inhibition of C1q in the eye for at least four weeks.

Key Points: 
  • In a Phase 1b trial, ANX007 was well-tolerated and demonstrated full target engagement and inhibition of C1q in the eye for at least four weeks.
  • ARCHER is a randomized, multi-center, double-masked, placebo-controlled Phase 2 clinical trial that enrolled a total of 270 patients with GA.
  • In a Phase 1b trial, ANX007 was well-tolerated and demonstrated full target engagement and inhibition of C1q in the eye for at least four weeks.
  • Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio.

BAE Systems’ 155mm ARCHER successfully completes U.S. Army’s shoot-off evaluation

Retrieved on: 
Monday, October 11, 2021
Manufacturing, Defense, Other Manufacturing, Other Defense, Contracts, Multimedia, Time, ARCHER, BAE Systems, Army, Swedish Army, Association of the United States Army, Walter E. Washington Convention Center, Maintenance, Walter, Yuma Proving Ground, Washington Convention Center, Excalibur, Association, Army of the United States, BAE, Explosive

BAE Systems, Inc.s 155mm ARCHER wheeled howitzer system successfully completed testing during the U.S. Armys shoot off evaluation, as the service evaluates whether to add a wheeled capability to its arsenal.

Key Points: 
  • BAE Systems, Inc.s 155mm ARCHER wheeled howitzer system successfully completed testing during the U.S. Armys shoot off evaluation, as the service evaluates whether to add a wheeled capability to its arsenal.
  • ARCHER is a fully automated mobile weapon system that provides highly responsive and versatile fire support to troops in combat.
  • The shoot off included charge compatibility with Army rounds, soldier training and testing, mobility, performance of Armys identified requirements, studying integrated digital fire control, and maintenance evaluation.
  • ARCHER is on display at BAE Systems booth during the Association of the United States Army exhibition in Washington, D.C. Oct. 11-13 at the Walter E. Washington Convention Center.

Archer Aviation Announces Closing of Business Combination with Atlas Crest Investment Corp. to Become A Publicly Traded Company

Retrieved on: 
Thursday, September 16, 2021
Other Manufacturing, Finance, Other Transport, Professional Services, Air, Aerospace, Transport, Manufacturing, U.S. Securities and Exchange Commission, Security (finance), ACIC, Moelis & Company, LLP, CEO, CA, Forward-looking statement, TWC Aviation, Inc., Company, LLC, PIPE, Cooley LLP, Atlas, Entrepreneurship, NYSE, City, Duff & Phelps, Multimedia, New, Barclays Capital Inc. v. Theflyonthewall.com, Inc., Business architecture, EVTOL, Aviation, Acquisition, Management, Risk management, Archer, Atlas Crest, ARCHER, ATLAS CREST

Archer Aviation Inc. announced today that it has closed its business combination with Atlas Crest Investment Corp. (NYSE: ACIC) (Atlas Crest), a special purpose acquisition company.

Key Points: 
  • Archer Aviation Inc. announced today that it has closed its business combination with Atlas Crest Investment Corp. (NYSE: ACIC) (Atlas Crest), a special purpose acquisition company.
  • Michael Spellacy, CEO of Atlas Crest, added, We are pleased to have reached this important milestone in closing our transaction with Archer.
  • Moelis & Company LLC served as exclusive financial advisor to Atlas Crest.
  • Duff & Phelps, LLC provided a fairness opinion in connection with the transaction to the Atlas Crest board of directors.

Atlas Crest Investment Corp. Shareholders Approve Business Combination with Archer Aviation Inc.

Retrieved on: 
Tuesday, September 14, 2021
Professional Services, Air, Transport, Finance, Accident, Form, U.S. Securities and Exchange Commission, Security (finance), ACIC, Helipad, Cell, Moelis & Company, Private Securities Litigation Reform Act, CA, Forward-looking statement, Urban air mobility, Marketing, Company, Risk, Special, PIPE, Probability, Crest, Aircraft, NYSE, Transport, City, COVID-19, New, Contract, Business architecture, EVTOL, Aviation, Acquisition, SEC, Sale, Holding company, Risk management, Archer, Atlas Crest, ARCHER, ATLAS CREST

Atlas Crest Investment Corp. (NYSE: ACIC) (Atlas Crest), a special purpose acquisition company, announced that its stockholders approved all proposals related to the previously announced business combination (the Business Combination) with Archer Aviation Inc. (Archer) at a special meeting of stockholders held today (the Special Meeting).

Key Points: 
  • Atlas Crest Investment Corp. (NYSE: ACIC) (Atlas Crest), a special purpose acquisition company, announced that its stockholders approved all proposals related to the previously announced business combination (the Business Combination) with Archer Aviation Inc. (Archer) at a special meeting of stockholders held today (the Special Meeting).
  • In connection with the vote on the Business Combination, approximately 48.5% of eligible shareholders exercised redemption rights.
  • Atlas Crest and Archer anticipate that subsequent events and developments will cause Atlas Crests and Archers assessments to change.
  • However, while Atlas Crest and Archer may elect to update these forward-looking statements at some point in the future, Atlas Crest and Archer specifically disclaim any obligation to do so.

Leading Independent Proxy Advisor, Glass Lewis, Recommends Atlas Crest Stockholders Vote “FOR” Business Combination with Archer

Retrieved on: 
Thursday, September 2, 2021
Finance, Banking, Air, Professional Services, Transport, Acquisition, City, Contract, EVTOL, COVID-19, Cell, Name, Form, Crest, Special, Moelis & Company, Forward-looking statement, Risk, ACIC, Workforce, Private Securities Litigation Reform Act, Completeness, CA, Probability, SEC, Aircraft, Accident, New, Business architecture, Company, Internet, Marketing, Helipad, Transport, Sale, NYSE, Holding company, Security (finance), Risk management, Atlas Crest, Archer, ATLAS CREST, ARCHER

Atlas Crest Investment Corp. (NYSE: ACIC) (Atlas Crest), a special purpose acquisition company, today announced that Glass Lewis, a leading independent proxy advisory firm, has issued a report recommending that Atlas Crest stockholders vote in favor of the previously announced business combination (the "Business Combination Proposal") with Archer Aviation Inc. (Archer''), a leading developer of an urban air mobility ecosystem and all-electric vertical takeoff and landing (eVTOL) aircraft.

Key Points: 
  • Atlas Crest Investment Corp. (NYSE: ACIC) (Atlas Crest), a special purpose acquisition company, today announced that Glass Lewis, a leading independent proxy advisory firm, has issued a report recommending that Atlas Crest stockholders vote in favor of the previously announced business combination (the "Business Combination Proposal") with Archer Aviation Inc. (Archer''), a leading developer of an urban air mobility ecosystem and all-electric vertical takeoff and landing (eVTOL) aircraft.
  • Atlas Crests board of directors recommends stockholders vote FOR the Business Combination and FOR all of the related proposals.
  • Stockholders can view Atlas Crests definitive proxy statement/prospectus here and the supplement to the definitive proxy statement/prospectus here .
  • Stockholders of record can also vote their shares electronically during the Special Meeting via live audio webcast by visiting https://www.cstproxy.com/atlascrestcorp/sm2021 .

Archer Aviation Inc. and Atlas Crest Investment Corp. to Host Fireside Chat with IPO Edge to Discuss Business Combination

Retrieved on: 
Tuesday, August 31, 2021
Air, Transport, Aerospace, Manufacturing, Maker, Company, Moelis & Company, Internet, Transport, Helipad, City, Form, Acquisition, EDT, Completeness, ACIC, SEC, Special, Private Securities Litigation Reform Act, New, Aircraft, CA, Name, Crest, Marketing, Cell, Forward-looking statement, NYSE, Probability, EVTOL, IPO, Risk, Workforce, Contract, Sale, Q&A, COVID-19, Urban air mobility, Accident, Air travel, Airline, Management, Security (finance), Risk management, Archer, Atlas Crest, ARCHER, ATLAS CREST

Stockholders can view Atlas Crests definitive proxy statement/prospectus here and Atlas Crests supplement to the definitive proxy statement/prospectus here .

Key Points: 
  • Stockholders can view Atlas Crests definitive proxy statement/prospectus here and Atlas Crests supplement to the definitive proxy statement/prospectus here .
  • These statements are subject to a number of risks and uncertainties regarding the businesses of Atlas Crest and Archer and the business combination, and actual results may differ materially.
  • Atlas Crest and Archer anticipate that subsequent events and developments will cause Atlas Crests and Archers assessments to change.
  • However, while Atlas Crest and Archer may elect to update these forward-looking statements at some point in the future, Atlas Crest and Archer specifically disclaim any obligation to do so.